Aclinical and immunological examination of men with occupational pathology, including vibration disease (VD), occupational sensorineural hearing loss (SHL), and chronic mercury intoxication (CMI), was carried out. The comparison group consisted of men comparable in age and total work experience. Serum concentrations of neurotrophins (S100β, MBP, BDNF) and antibodies (ABs) to S100β and MBP proteins were determined by enzyme-linked immunosorbent assay. An increase in the level of the S100β protein was shown in CMI, VD, and a tendency for its increase was found in SHL. In parallel, an increase in AB to the S100β protein in VD and SHL and a decrease in AB in CMI were noted. A comparative assessment of MBP levels indicated a pronounced increase in its serum concentrations in patients with CMI and VD versus the comparison group. At the same time, an increase in the level of serum ABs to MBP in individuals with VD and SHL, and a decrease in patients with CMI were noted. In patients with CMI, a significant decrease in the BDNF concentration was found, while in SHL and VD, no statistically significant differences were found in comparison with the comparison group. The results obtained confirm importance of assessing serum concentrations of neurotrophic proteins and ABs to them in the case of occupational damage to the nervous system caused by exposure to physical and chemical factors.
Bodienkova G.M., Boklazhenko E.V. (2024) Altered serum levels of neuronal proteins and antibodies to them in occupational diseases of the nervous system. Biomeditsinskaya Khimiya, 70(2), 109-113.
Bodienkova G.M. et al. Altered serum levels of neuronal proteins and antibodies to them in occupational diseases of the nervous system // Biomeditsinskaya Khimiya. - 2024. - V. 70. -N 2. - P. 109-113.
Bodienkova G.M. et al., "Altered serum levels of neuronal proteins and antibodies to them in occupational diseases of the nervous system." Biomeditsinskaya Khimiya 70.2 (2024): 109-113.
Bodienkova, G. M., Boklazhenko, E. V. (2024). Altered serum levels of neuronal proteins and antibodies to them in occupational diseases of the nervous system. Biomeditsinskaya Khimiya, 70(2), 109-113.
References
Hosang G.M., Uher R., Keers R., Cohen-Woods S., Craig I., Korszun A., Perry J., Tozzi F., Muglia P., McGuffin P., Farmer A.E. (2010) Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J.Affect. Disord., 125(1-3), 345-349. CrossRef Scholar google search
Bodienkova G.M., Boklazhenko E.V. (2023) Immunochemical markers of effect under exposure to risk factors causing vibration disease of different etiogenesis: Comparative assessment. Analiz Riska Zdorov'yu, 2, 149-154. CrossRef Scholar google search
Kryzhanovskaya S.Yu., Zapara M.A., Glazachev O.S. (2020) Neurotrophins and Adaptation to Environmental Stimuli: Opportunities to Expand “Therapeutic Potential” (Summary). Vestnik Mezhdunarodnoy Akademii Nauk (Russkaya Sektsiya), 1, 36-43. Scholar google search
Kobeissy F., Moshourab A.R. (2015) Autoantibodies in CNS Trauma and Neuropsychiatric Disorders: A New Generation of Biomarkers. In: Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects (Firas H., Kobeissy F.H., eds.), Boca Raton (FL), CRC Press/Taylor and Francis, Chapter 29. CrossRef Scholar google search
Lopresti A.L., Maker G.L., Hood S.D., Drummond P.D. (2014) A reviews of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Prog. Neuropsychopharmacol. Biol. Psychiatry, 3(48), 102-111. CrossRef Scholar google search
Gusev E.I., Boyko A.N. (2000) Demyelinating diseases of the central nervous system. Consilium Medicum, 2(2), 84-88. Scholar google search
Markelova E.V., Zenina A.A., Kadyrov R.V. (2018) Neuropeptides as markers of brain damage. Sovremennye Problemy Nauki i Obrazovaniya, 5, 206. Scholar google search
Matusica D., Coulson E.J. (2014) Local versus long-range neurotrophin receptor signalling: endosomes are not just carriers for axonal transport. Semin. Cell Dev. Biol., 31, 57-63. CrossRef Scholar google search
Katamanova E.V., Bichev S.S., Nurbayeva D.Zh. (2012) Value of brain structure dysfunction in pathogenesis and formation of clinical picture of vibration induced disease. Byulleten' Vostochno-Sibirskogo Nauchnogo Tsentra Sibirskogo Otdeleniya Rossiyskoy Akademii Meditsinskikh Nauk, 83(1), 32-36. Scholar google search
Astakhin A.V., Evlasheva O.O., Levitan B.N. (2016) Clinical and diagnostic significance of myelin basic protein and neuron-specific enolase in medical practice. Astrakhanskiy Meditsinskiy Zhurnal, 11(4), 9-17. Scholar google search
Shvaikovskaya A.A., Zhanaeva S.Y., Evsyukova A.V., Tikhonova M.A., Danilenko K.V., Aftanas L. (2020) Brain neurotrophic factor (BDNF) and its diagnostic significance when measured in blood: Analytical review. Yakutskiy Meditsinskiy Zhurnal, 71(3), 105-110. CrossRef Scholar google search
de Assis G.G., de Almondes K.M. (2017) Exercise-dependent BDNF as a modulatory factor for the executive processing of individuals in course of cognitive decline. A systematic review. Front. Psychol., 8, 584. CrossRef Scholar google search
Lipatova L.V., Serebryannaya N.B., Kapustina T.V., Sivakova N.A. (2017) Brain neuroplasticity as a predictor of the therapeutic response of patients with epilepsy and associated depression. Allergologiya i Immunologiya, 18(1), 60. Scholar google search
Ermakov E.A., Melamud M.M., Nevinsky G.A., Buneva V.N. (2022) Analysis of the hydrolysis of peptides of functionally important regions of brain and glial neurotrophic factors by antibodies of patients with schizophrenia and other neuroimmune diseases. Siberian Herald of Psychiatry and Addiction Psychiatry, 4(117), 5-13. CrossRef Scholar google search
Orlova V.A., Mikhaylova I.I., Minutko V.L., Simonova A.V. (2016) Abnormalities of levels of serum autoantibodies to the antigens of nervous tissue microstructures in patients with schizophrenia: Multiparametric immunological assessment. Social and Clinical Psychiatry, 26(1), 12-20. Scholar google search
Bodienkova G.M., Boklazhenko E.V., Katamanova E.V. (2012) clinical value of regulatory autoantibodies in development of neurointoxication with metallic mercury vapours. Byulleten' Vostochno-Sibirskogo Nauchnogo Tsentra Sibirskogo Otdeleniya Rossiyskoy Akademii Meditsinskikh Nauk, 84(2-1), 20-23. Scholar google search
